deferoxamine has been researched along with Hallucinations in 1 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
Excerpt | Relevance | Reference |
---|---|---|
"In the first case, paranoid delusions, visual hallucinations, seizures and deteriorating speech followed each dialysis treatment with DFO." | 1.28 | Exacerbation of aluminium encephalopathy after treatment with desferrioxamine. ( McCauley, J; Sorkin, MI, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McCauley, J | 1 |
Sorkin, MI | 1 |
1 other study available for deferoxamine and Hallucinations
Article | Year |
---|---|
Exacerbation of aluminium encephalopathy after treatment with desferrioxamine.
Topics: Aged; Aluminum Hydroxide; Deferoxamine; Hallucinations; Humans; Male; Memory Disorders; Middle Aged; | 1989 |